Regulatory Role of Chemerin in Lung Tumorigenesis and Cancer-associated Inflammation

Original Article

Anti-inflammatory effect of chemerin in cancer

  • Nese Unver
  • Guldal Yilmaz
  • Hande Canpinar
  • Dicle Guc
  • Gunes Esendagli

Abstract

Objective: Interaction between the chemokine-like receptor 1 (CMKLR1) and its cognate peptide ligand, chemerin, can downregulate the inflammatory responses. This study investigates the regulatory role chemerin in lung tumorigenesis and cancer-associated inflammation.

Materials and methods: Animal experiments, cell culture, gene cloning and transfection, chemotaxis assay, Lewis lung carcinoma (LLC) tumorigenesis assays, histopathological evaluation, mixed leukocyte reactions, flow cytometry, proliferation and clonogenicity assays, reverse transcription-polymerase chain reaction (RT-PCR), enzyme-linked immunosorbent assay (ELISA), and immunohistochemistry (IHC) techniques were used.

Results: CMKLR1 was identified in mouse LLC tumors. The LLC cells were modified to secrete prochemerin at a level that cannot induce chemotactic activity. Inflammatory cytokine expression, TNF-α, IL-12 p40, but not IL-1β, was diminished in leukocytes when exposed to conditioned media obtained from the chemerin-expressing LLC cells, and in the tumors established with those cells. On the other hand, leukocyte proliferation and IFN-γ expression were not drastically impeded. Correspondingly, tumor forming capacity of the chemerin-expressing LLCs was decreased.

Conclusion: Chemerin may possess a potential to modulate the inflammatory responses in the tumor microenvironment.

Downloads

Download data is not yet available.
Published
Mar 31, 2018
How to Cite
UNVER, Nese et al. Regulatory Role of Chemerin in Lung Tumorigenesis and Cancer-associated Inflammation. Acta Medica, [S.l.], v. 49, n. 1, mar. 2018. ISSN 2147-9488. Available at: <https://actamedica.org/index.php/actamedica/article/view/278>. Date accessed: 16 july 2018.
Section
Original Article